Pons-Estel GJ - Search Results

1

Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.

Pons-Estel GJ, González LA, Zhang J, Burgos PI, Reveille JD, Vilá LM, Alarcón GS. Pons-Estel GJ, et al. Rheumatology (Oxford). 2009 Jul;48(7):817-22. doi: 10.1093/rheumatology/kep102. Epub 2009 May 19. Rheumatology (Oxford). 2009. PMID: 19454606 Free PMC article.

2

Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry.

Yazdany J, Ware A, Wallace ZS, Bhana S, Grainger R, Hachulla E, Richez C, Cacoub P, Hausmann JS, Liew JW, Sirotich E, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Ribeiro SLE, Al-Emadi S, Hasseli R, Müller-Ladner U, Specker C, Schulze-Koops H, Bernardes M, Fraga VM, Rodrigues AM, Sparks JA, Ljung L, Di Giuseppe D, Tidblad L, Wise L, Duarte-García A, Ugarte-Gil MF, Colunga-Pedraza IJ, Martínez-Martínez MU, Alpizar-Rodriguez D, Xavier RM, Isnardi CA, Pera M, Pons-Estel G, Izadi Z, Gianfrancesco MA, Carrara G, Scirè CA, Zanetti A, Machado PM. Yazdany J, et al. Arthritis Care Res (Hoboken). 2024 Feb;76(2):274-287. doi: 10.1002/acr.25220. Epub 2023 Nov 7. Arthritis Care Res (Hoboken). 2024. PMID: 37643903

3

2023 ACR/EULAR antiphospholipid syndrome classification criteria.

Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesús G, Delluc A, Desai S, Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-García A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28. Ann Rheum Dis. 2023. PMID: 37640450

4

Understanding the epidemiology and progression of systemic lupus erythematosus.

Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Pons-Estel GJ, et al. Semin Arthritis Rheum. 2010 Feb;39(4):257-68. doi: 10.1016/j.semarthrit.2008.10.007. Epub 2009 Jan 10. Semin Arthritis Rheum. 2010. PMID: 19136143 Free PMC article. Review.

5

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

Danila MI, Pons-Estel GJ, Zhang J, Vilá LM, Reveille JD, Alarcón GS. Danila MI, et al. Rheumatology (Oxford). 2009 May;48(5):542-5. doi: 10.1093/rheumatology/kep012. Epub 2009 Feb 20. Rheumatology (Oxford). 2009. PMID: 19233884 Free PMC article.

6

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.

Pons-Estel GJ, Alarcón GS, McGwin G Jr, Danila MI, Zhang J, Bastian HM, Reveille JD, Vilá LM; Lumina Study Group. Pons-Estel GJ, et al. Arthritis Rheum. 2009 Jun 15;61(6):830-9. doi: 10.1002/art.24538. Arthritis Rheum. 2009. PMID: 19479701 Free PMC article.

7

Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution.

Burgos PI, Perkins EL, Pons-Estel GJ, Kendrick SA, Liu JM, Kendrick WT, Cook WJ, Julian BA, Alarcón GS, Kew CE 2nd. Burgos PI, et al. Arthritis Rheum. 2009 Sep;60(9):2757-66. doi: 10.1002/art.24776. Arthritis Rheum. 2009. PMID: 19714623 Free PMC article.

8

Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.

Pons-Estel GJ, Alarcón GS, González LA, Zhang J, Vilá LM, Reveille JD, McGwin G Jr; Lumina Study Group. Pons-Estel GJ, et al. Arthritis Care Res (Hoboken). 2010 Mar;62(3):393-400. doi: 10.1002/acr.20097. Arthritis Care Res (Hoboken). 2010. PMID: 20391486 Free PMC article.

9

US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV).

Burgos PI, McGwin G Jr, Pons-Estel GJ, Reveille JD, Alarcón GS, Vilá LM. Burgos PI, et al. Ann Rheum Dis. 2011 Feb;70(2):393-4. doi: 10.1136/ard.2010.131482. Epub 2010 Jul 13. Ann Rheum Dis. 2011. PMID: 20627945 Free PMC article. No abstract available.

10

Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort.

Pons-Estel GJ, Alarcón GS, Hachuel L, Boggio G, Wojdyla D, Pascual-Ramos V, Soriano ER, Saurit V, Cavalcanti FS, Guzman RA, Guibert-Toledano M, Sauza Del Pozo MJ, Amigo MC, Alva M, Esteva-Spinetti MH, Pons-Estel BA; GLADEL. Pons-Estel GJ, et al. Rheumatology (Oxford). 2012 Jul;51(7):1293-8. doi: 10.1093/rheumatology/ker514. Epub 2012 Mar 2. Rheumatology (Oxford). 2012. PMID: 22389125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page